Open Your Free Demat Account
Enjoy low brokerage on delivery trades
Gujarat Kidney and Superspeciality Hospital Limited opened its initial public offering for subscription, with the second day witnessing mixed participation across investor categories. Retail investor demand was the highest for the day , while interest from Qualified Institutional Buyers (QIBs) was relatively muted. Participation from Non-Institutional Investors (NIIs) showed moderate traction during the session.
The issue is a public offering with allocations across QIBs, NIIs, retail investors, and anchor investors. Anchor investor allocation was completed prior to the opening of the public issue.
Below is a detailed snapshot of the IPO’s subscription status and issue structure as of today.
To explore full offer details, visit the Gujarat Kidney and Superspeciality Hospital IPO page.
As of 5:01 PM on December 24, 2025 , the Gujarat Kidney and Superspeciality Hospital IPO was subscribed 5.21 times overall.
The retail investor portion was subscribed 19.02 times, reflecting relatively higher participation from individual investors. The NII segment recorded subscriptions of 5.73 times, while the QIB (ex-anchor) category was subscribed 1.06 times.
Subscription Table
Investor Category | Subscription (x) | Shares Offered* | Shares bid for | Total Amount* (Rs Cr.) |
Anchor Investors | 1 | 87,73,120 | 87,73,120 | 100.01 |
QIB (Ex Anchor) | 1.06 | 77,26,880 | 81,88,928 | 93.35 |
Non-Institutional Buyers | 5.73 | 33,00,000 | 1,88,96,256 | 215.42 |
bNII (bids above ₹10L) | 5.25 | 22,00,000 | 1,15,52,896 | 131.70 |
sNII (bids below ₹10L) | 6.68 | 11,00,000 | 73,43,360 | 83.71 |
Retail Investors | 19.02 | 22,00,000 | 4,18,51,008 | 477.10 |
Total ** | 5.21 | 1,32,26,880 | 6,89,36,192 | 785.87 |
Total Applications Received: 2,59,761
Notes:
“Shares Offered” and “Total Amount” are calculated at the upper price of the issue price band.
Anchor investor shares are excluded from public subscription totals.
Gujarat Kidney and Superspeciality Hospital IPO is a public issue of 2.20 crore equity shares, allocated across QIBs, NIIs, and retail investors.
Category | Shares Offered | Amount (₹ Cr) | Size (%) |
QIB | 1,65,00,000 | 188.10 | 75.00% |
• Anchor Investors | 87,73,120 | 100.01 | 39.88% |
• QIB (Ex Anchor) | 77,26,880 | 88.09 | 35.12% |
NII | 33,00,000 | 37.62 | 15.00% |
• bNII (above ₹10L) | 22,00,000 | 25.08 | 10.00% |
• sNII (below ₹10L) | 11,00,000 | 12.54 | 5.00% |
Retail | 22,00,000 | 25.08 | 10.00% |
Total | 2,20,00,000 | 250.80 | 100% |
Issue size calculated at the upper end of the price band.
As per the stated objectives, the net proceeds from the Gujarat Kidney and Superspeciality Hospital IPO are proposed to be utilised towards:
Capital expenditure for hospital infrastructure and medical equipment
Expansion of clinical facilities
General corporate purposes
A total of 87,73,120 equity shares were allotted to anchor investors at a price of ₹114 per share.
Parameter | Details |
Anchor investor bid opening date | December 19, 2025 |
Anchor investor price | ₹114.00 |
Anchor investors as % of QIBs | — |
Shares locked-in for 30 days | — |
Shares locked-in for 90 days | — |
Click here to check out recently closed IPO
Today, the Gujarat Kidney and Superspeciality Hospital IPO witnessed strong participation from retail investors, while subscription levels in the QIB segment remained comparatively lower. NII participation showed moderate traction during the session.
Subscription levels across categories may evolve as the issue progresses over the remaining days. Investors can continue to track daily subscription updates, allotment
Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Gujarat Kidney and Superspeciality Hospital IPO.
Disclaimer :
Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Content Partner - Dalal Street Investment Journal Wealth Advisory Private Limited
This article is for educational purposes only and should not be considered investment advice. Market investments are subject to risks. DSIJ Wealth Advisory Private Limited is a SEBI-registered Research Analyst (Reg. No: INH000006396) and Investment Adviser (Reg. No: INA000001142). Please consult your financial adviser before investing.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading